Herve Rhinn-profileHerve Rhinn, PhD
Asa Abeliovich-profileAsa Abeliovich, MD, PhD

Citizen Scientist Summaries_Hypothesis 3 (PDF)

Abstract-Herve Rhinn and Asa Beliovich (PDF)

Presentation Herve Rhinn and Asa Abeliovich (PDF)

CV Herve Rhinn (PDF)

CV Asa Abeliovich (PDF)

Herve Rhinn, PhD

After an initial training in mathematics/physics and an engineering degree from the Ecole Polytechnique (France), Herve Rhinn obtained a PhD in molecular biology at Pierre and Marie University (Paris, France). He then joined Asa Abeliovich’s lab at Columbia University ( New York) as a postdoc to work on neurodegenerative diseases. He developed gene expression network tools and applied integrative functional genomics and genetic approaches to the study of the sporadic forms of Alzheimer’s and Parkinson’s Diseases, relying for the most part on innovative re-analysis of publicly deposited dataset. He highlighted a pathogenic role for alpha-synuclein transcripts with extended 3’untranslated region in Parkinson’s Disease and identified molecular effectors of APOE in Alzheimer’s Disease. Now an assistant professor, he works between Paris and New York.

When learning about the Challenge on Nature’s website he was thrilled at the perspective of applying the methods he developed to study effector of Alzheimer’s Disease genetic risks such as APOE to other factor such as gender: even though having no personal connection with Alzheimer’s Disease, participating in untangling the puzzle of this disease has become, through his work, an important part of his life. He formulated his Solution of the Challenge away from everything in the mountains in the South of France during vacations right after the birth of his second daughter.

Asa Abeliovich, MD, PhD

Dr. Abeliovich is currently an Associate Professor of Pathology, Cell Biology, and Neurology at Columbia University (with Tenure) and an Attending Physician at New York Presbyterian Hospital. He is also a member of the Taub Institute for Alzheimer’s Disease and the Aging Brain. Dr. Abeliovich grew up in rural Illinois and subsequently attended MIT, where he received bachelor’s degrees in Life Sciences and Humanities. Dr. Abeliovich then earned MD and PhD degrees from Harvard Medical School and MIT, respectively, through a joint Medical Scholar Training Program Fellowship. At MIT, Dr. Abeliovich undertook thesis research in the laboratory of Dr. Susumu Tonegawa, where he pioneered studies on the molecular mechanisms of learning and memory in mammals. Dr. Abeliovich completed clinical training in Neurology at UCSF. At Genentech, Inc., in South San Francisco, he initiated research on molecular mechanisms of Parkinson’s disease in the laboratory of Dr. Arnon Rosenthal. He was awarded the Lamport award for excellence in basic science research at Columbia University in 2005.